儿童院外心脏骤停后急性肾损伤
该研究为THAPCA-OH试验的事后二次分析,纳入美国与加拿大36个儿童重症监护病房282例院外心脏骤停后昏迷患儿,148例随机至治疗性低温、134例随机至治疗性常温。180例(64%)发生急性肾损伤,其中117例(占全部41%)为重度急性肾损伤(KDIGO 2–3期)。多变量模型显示更小年龄、更长胸外按压时间、温度干预时更高乳酸水平及干预第1天更多血管活性药物与重度急性肾损伤相关。治疗性低温组重度急性肾损伤39.9%与治疗性常温组43.3%无差异(p=0.629)。重度急性肾损伤者28天生存21% vs 无重度急性肾损伤49%(p<0.001),12个月生存21% vs 42%(p<0.001),1年生存且功能预后良好者更少。
要点
- 院外心脏骤停后昏迷患儿中64%(180/282)发生急性肾损伤,41%(117/282)为KDIGO 2–3期重度急性肾损伤。
- 重度急性肾损伤者28天生存21% vs 无重度急性肾损伤49%(p<0.001),12个月生存21% vs 42%(p<0.001)。
- 治疗性低温组重度急性肾损伤39.9% vs 治疗性常温组43.3%,无差异(p=0.629)。
- 更小年龄、更长胸外按压时间、温度干预时更高乳酸水平、干预第1天更多血管活性药物与重度急性肾损伤相关。
- 重度急性肾损伤者1年生存且功能预后良好者更少。
适用人群与场景
- 美国与加拿大36个儿童重症监护病房中院外心脏骤停后昏迷患儿,随机分组后24小时内取得初始肌酐的282例合格受试者。
- 148例随机至治疗性低温,134例随机至治疗性常温。
诊断标准与关键阈值
- 重度急性肾损伤定义为KDIGO共识定义的2期和3期。
研究设计与关键结果
- 研究类型为THAPCA-OH试验的事后二次分析,36个儿童重症监护病房,282例受试者,148例治疗性低温 vs 134例治疗性常温。
- 180例(64%)发生急性肾损伤,其中117例(占全部41%)为重度急性肾损伤。
- 多变量模型显示更小年龄、更长胸外按压时间、温度干预时更高乳酸水平、干预第1天更多血管活性药物与重度急性肾损伤相关。
- 重度急性肾损伤发生率治疗性低温组39.9% vs 治疗性常温组43.3%(p=0.629),无差异。
- 28天生存:重度急性肾损伤者21% vs 无重度急性肾损伤者49%(p<0.001)。
- 12个月生存:重度急性肾损伤者21% vs 无重度急性肾损伤者42%(p<0.001)。
- 重度急性肾损伤者1年生存且功能预后良好者更少。
证据类型、等级与局限
- 证据类型为随机对照试验的事后二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为重度急性肾损伤在院外心脏骤停复苏后儿童中常见,尤其见于更小年龄、更高初始乳酸及需要血流动力学支持的患儿。
- 作者认为重度急性肾损伤与更差生存及功能预后相关。
- 作者认为治疗性低温未降低重度急性肾损伤的发生率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Many children with return of spontaneous circulation (ROSC) following cardiac arrest (CA) experience acute kidney injury (AKI). The impact of therapeutic hypothermia on the epidemiology of post-CA AKI in children has not been fully investigated.
OBJECTIVE: The study aims were to: 1) describe the prevalence of severe AKI in comatose children following out-of-hospital CA (OHCA), 2) identify risk factors for severe AKI, 3) evaluate the impact of therapeutic hypothermia on the prevalence of severe AKI, and 4) evaluate the association of severe AKI with survival and functional outcomes.
DESIGN: A post hoc secondary analysis of data from the Therapeutic Hypothermia after Pediatric Cardiac Arrest Out-of-Hospital (THAPCA-OH) trial.
SETTING: Thirty-six pediatric intensive care units in the United States and Canada.
PARTICIPANTS: Of 282 eligible subjects with an initial creatinine obtained within 24 h of randomization, 148 were randomized to therapeutic hypothermia and 134 were randomized to therapeutic normothermia.
MAIN OUTCOMES AND MEASURES: Primary outcome was prevalence of severe AKI, as defined by stage 2 and 3 Kidney Disease Improving Global Outcomes (KDIGO) consensus definition; secondary outcome was survival with a favorable neurobehavioral outcome. For this study, risk factors and outcomes were compared between those with/without severe AKI.
RESULTS: Of the 282 subjects enrolled, 180 (64%) developed AKI of which 117 (41% of all enrolled) developed severe AKI. Multivariable modeling found younger age, longer duration of chest compressions, higher lactate level at time of temperature intervention and higher number of vasoactive agents through day 1 of intervention associated with severe AKI. There was no difference in severe AKI between therapeutic hypothermia (39.9%) and therapeutic normothermia (43.3%) groups (p = 0.629). Survival was lower in those with severe AKI at 28 days (21% vs no severe AKI 49%, p < 0.001) and 12 months (21% vs no severe AKI 42%, p < 0.001). One year survival with favorable functional outcome was lower in those with severe AKI.
CONCLUSIONS AND RELEVANCE: Severe AKI occurs frequently in children with ROSC after OHCA, especially in younger children and those with higher initial lactates and hemodynamic support. Severe AKI was associated with worse survival and functional outcome. Therapeutic hypothermia did not reduce the incidence of severe AKI.
参考来源
- Cornell TT, Selewski DT, Alten JA, et al. Acute kidney injury after out of hospital pediatric cardiac arrest. Resuscitation. 2018. PMID: 30075198. doi:10.1016/j.resuscitation.2018.07.362
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。